Compare · BBLN vs HIMS
BBLN vs HIMS
Side-by-side comparison of Babylon Holdings Limited (BBLN) and Hims & Hers Health Inc. (HIMS): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both BBLN and HIMS operate in Medical/Nursing Services (Health Care), so they compete in similar markets.
- HIMS is the larger of the two at $6.85B, about 3.0x BBLN ($2.27B).
- HIMS has hit the wire 9 times in the past 4 weeks while BBLN has been quiet.
- HIMS has more recent analyst coverage (25 ratings vs 9 for BBLN).
- Company
- Babylon Holdings Limited
- Hims & Hers Health Inc.
- Price
- $0.55-13.27%
- $28.05-4.54%
- Market cap
- $2.27B
- $6.85B
- 1M return
- -
- +0.70%
- 1Y return
- -
- -45.38%
- Industry
- Medical/Nursing Services
- Medical/Nursing Services
- Exchange
- NYSE
- NYSE
- IPO
- 2019
- News (4w)
- 0
- 9
- Recent ratings
- 9
- 25
Babylon Holdings Limited
Babylon Holdings Limited operates as a digital healthcare company in the United Kingdom and internationally. Its digital-first platform provides with assistance to navigate the health system by connecting patients digitally to the clinicians. The company was founded in 2013 and is headquartered in London, the United Kingdom.
Hims & Hers Health Inc.
Hims & Hers Health, Inc. operates a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals. The company offers a range of health and wellness products and services available for purchase on its websites directly by customers. It provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, as well as cosmetics and supplement products, primarily focusing on wellness, sexual health, skincare, and hair care. The company's curated non-prescription products include vitamin C, melatonin, collagen protein, biotin, and teas in the wellness category; moisturizer, fragrances, face wash, and anti-wrinkle creams in the skincare category; condoms and lubricants in the sexual health category; and shampoos, conditioners, scalp scrubs, and topical treatments, such as minoxidil in the hair care category. It also offers medical consultation services; and engages in the wholesale of non-prescription product sales to retailers. Hims & Hers Health, Inc. is based in San Francisco, California.
Latest BBLN
- Babylon Holdings Limited filed SEC Form 8-K: Other Events
- Babylon Holdings Limited filed SEC Form 8-K: Other Events
- SEC Form NT 10-Q filed by Babylon Holdings Limited
- Babylon Holdings Limited filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
- Babylon Holdings Limited filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits
- SEC Form 25-NSE filed by Babylon Holdings Limited
- SEC Form 4 filed by Vnv Global Ab (Publ)
- SEC Form SC 13D/A filed by Babylon Holdings Limited (Amendment)
- SEC Form 4 filed by Vnv Global Ab (Publ)
- Babylon Holdings Announces Receipt Of Continued Listing Standards Notice From NYSE And Upcoming Delisting
Latest HIMS
- SEC Form 4 filed by Hims & Hers Health Inc.
- SEC Form 3 filed by Hims & Hers Health Inc.
- Hims & Hers to Announce Third Quarter 2026 Financial Results on November 9, 2026
- Hers Launches in Australia, Built to Care for the Whole Woman
- SEC Form 8-K filed by Hims & Hers Health Inc.
- Hims & Hers Names Jon Franklin as Chief Accounting Officer
- Chief Financial Officer Okupe Oluyemi sold $59,400 worth of shares (2,000 units at $29.70) as part of a pre-agreed trading plan, decreasing direct ownership by 0.85% to 234,527 units (SEC Form 4)
- Chief Legal Officer Boughton Soleil sold $100,957 worth of shares (3,461 units at $29.17) as part of a pre-agreed trading plan, decreasing direct ownership by 1% to 300,809 units (SEC Form 4)
- Hims & Hers Names Chief Medical Officers in the UK and Australia, Deepening its Investment in Local Clinical Leadership
- Chief Financial Officer Okupe Oluyemi sold $876,846 worth of shares (29,277 units at $29.95) as part of a pre-agreed trading plan and exercised 14,000 shares at a strike of $5.01, decreasing direct ownership by 6% to 236,527 units (SEC Form 4)